StockData
MAIA Biotechnology, Inc. logo

MAIA Biotechnology, Inc. (MAIA) stock

MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$1.30+0.05 (+4.00%)

Close on Nov 18, 2026Market cap $79.07MP/E –Yield –

MAIA Biotechnology operating margin

Operating margin is operating income as a percentage of revenue.

No operating margin figures for MAIA Biotechnology

MAIA Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More MAIA Biotechnology figures

See a number that looks wrong?